§ 520.1705 Pergolide.
Primary source
Verbatim text below is from the Electronic Code of Federal Regulations (eCFR), a public-domain U.S. government work. Always verify the current version with the eCFR before relying on it for any legal matter.
Full Text
(a) Specifications. Each tablet contains 1 milligram (mg) pergolide (as pergolide mesylate).
(b) Sponsor. See Nos. 000010 and 017033 in § 510.600(c) of this chapter.
(c) Conditions of use in horses—(1) Amount. Administer orally at a starting dose of 2 micrograms/kilograms (µ/kg) once daily. Dosage may be adjusted to effect, not to exceed 4 µg/kg daily.
(2) Indications for use. For the control of clinical signs associated with Pituitary Pars Intermedia Dysfunction (Equine Cushing's Disease).
(3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[77 FR 15960, Mar. 19, 2012, as amended at 81 FR 22523, Apr. 18, 2016; 91 FR 20341, Apr. 16, 2026]
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.